Fresenius Kabi expands medical device production in Nanchang, China

Fresenius Kabi has expanded its Nanchang subsidiary five times over 22 years with total investment of nearly 600 million yuan ($82.9 million). The company decided to centralize all clinical nutrition device production in Nanchang, making it a key R&D and production base.

“We have now decided to centralize everything about medical devices for clinical nutrition here in Nanchang because it's much more competitive.”chinadaily.com.cn

• 1 source
• chinadaily.com.cnMedtech company continues expansion in China - Chinadaily.com.cn马清Apr 19, 2024

Summarized from public sources; check the original articles before acting on it.